Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma

Pancreatology

Volumn 2, Issue 2, 2002, Pages 129-137

  Joo, Young Eun ^a   Rew, Jong Sun ^a   Park, Chang Soo ^a   Kim, Sei Jong ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Catenins; E Cadherin; Immunohistochemistry; Pancreatic adenocarcinoma

Indexed keywords

ALPHA CATENIN; BETA CATENIN; UVOMORULIN;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0036284906     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000055903     Document Type: Article

References (35)

1. Cadherin cell adhesion receptor as a morphogenetic regulator
2. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion
3. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species
4. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of cell adhesion molecule
5. Cell binding function of E-cadherin is regulated by the cytoplasmic domain
6. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
7. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
8. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer
9. Expression of E-cadherin adhesion molecules in human breast cancer tissues and its relationship to metastasis
10. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis
11. Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis
12. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival
13. Loss of membranous E-cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage
14. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer
15. Expression and potential role of E-cadherin in pancreatic carcinoma
16. Pancreatic carcinoma: Correlation between E-cadherin and α-catenin expression status and liver metastasis
17. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines
18. Reduced membranous and ectopic cytoplasmic expression of beta-catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer
19. Tumors of pancreas
20. Complete one-hour immunohistochemistry based on capillary action
21. Cadherins in cancer: Implications for invasion and metastasis
22. Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions
23. Cadherin-catenin complex: Protein interactions and their implications for cadherin function
24. Analysis of beta-catenin gene mutations in pancreatic tumors
25. Induction of a secondary body axis in Xenopus by antibodies to β-catenin
26. β- and γ-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer
27. AGA technical review on the epidemiology, diagnosis and treatment of pancreatic ductal adenocarcinoma
28. Surgical treatment of pancreatic cancer: The United States experience
29. Mutation of the human E-cadherin (CDH1) gene
30. Downregulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines
31. Beta-catenin as oncogene: The smoking gun
32. Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor
33. Aberrant expression and phosphorylation of β-catenin in human colorectal cancer
34. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma